FAIS, FRANCO
 Distribuzione geografica
Continente #
EU - Europa 10.477
AS - Asia 1.377
NA - Nord America 1.185
Continente sconosciuto - Info sul continente non disponibili 160
SA - Sud America 124
AF - Africa 32
OC - Oceania 1
Totale 13.356
Nazione #
IT - Italia 10.253
US - Stati Uniti d'America 1.107
SG - Singapore 515
CN - Cina 349
VN - Vietnam 241
BD - Bangladesh 133
FR - Francia 87
BR - Brasile 72
HK - Hong Kong 47
CA - Canada 34
DE - Germania 32
AR - Argentina 24
FI - Finlandia 24
JP - Giappone 15
GB - Regno Unito 14
JM - Giamaica 14
CH - Svizzera 13
ID - Indonesia 13
IQ - Iraq 13
MX - Messico 12
ZA - Sudafrica 11
RU - Federazione Russa 8
UA - Ucraina 8
CR - Costa Rica 7
ES - Italia 7
IN - India 7
CO - Colombia 6
PH - Filippine 6
PK - Pakistan 6
DZ - Algeria 5
EC - Ecuador 5
IE - Irlanda 5
NL - Olanda 5
TR - Turchia 5
PE - Perù 4
BO - Bolivia 3
CL - Cile 3
EG - Egitto 3
GT - Guatemala 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
PL - Polonia 3
PY - Paraguay 3
RS - Serbia 3
TW - Taiwan 3
VE - Venezuela 3
AL - Albania 2
AT - Austria 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
HN - Honduras 2
JO - Giordania 2
NG - Nigeria 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
MZ - Mozambico 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
UZ - Uzbekistan 1
Totale 13.198
Città #
Genova 5.276
Genoa 3.203
Rapallo 878
Vado Ligure 754
San Jose 316
Singapore 240
Ashburn 140
Lauterbourg 79
Ho Chi Minh City 71
Beijing 64
Hanoi 47
Hong Kong 43
New York 38
Council Bluffs 27
Santa Clara 25
Helsinki 24
Los Angeles 24
Frankfurt am Main 21
Bordighera 19
Buffalo 15
Milan 15
Dallas 13
Tokyo 13
Da Nang 12
Boardman 11
Bologna 11
Zurich 11
St Louis 10
Mexico City 9
Orem 9
Guangzhou 8
Haiphong 8
Kingston 8
Rome 8
São Paulo 8
Chicago 7
Atlanta 6
Biên Hòa 6
City of London 6
Johannesburg 6
Madrid 6
Nuremberg 6
San José 6
Turin 6
Brasília 5
Brooklyn 5
Dublin 5
Hixson 5
Montreal 5
Philadelphia 5
Queens 5
Seattle 5
Toronto 5
Baghdad 4
Chennai 4
Cincinnati 4
Kyiv 4
Miami 4
Naples 4
Tampa 4
The Bronx 4
Tianjin 4
Almaty 3
Augusta 3
Aurora 3
Bari 3
Bắc Ninh 3
Cairo 3
Can Tho 3
Cape Coral 3
Cape Town 3
Changsha 3
Chula Vista 3
Cochabamba 3
Denver 3
Dhaka 3
Egg Harbor Township 3
Figino 3
Garland 3
Houston 3
Kansas City 3
Leander 3
London 3
Managua 3
Milwaukee 3
Minneapolis 3
Moscow 3
Nha Trang 3
Ninh Bình 3
Phoenix 3
Phú Thọ 3
Phủ Lý 3
San Antonio 3
San Miguel de Tucumán 3
Spokane 3
Sulaymaniyah 3
Washington 3
Wuppertal 3
Acalanes Ridge 2
Amman 2
Totale 11.706
Nome #
A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells 241
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells. 226
N-(4-hydroxyphenyl) retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates Fludarabine and ABT-737 cytotoxicity 223
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. 204
Human cytomegalovirus regulates surface expression of the viral protein UL18 by means of two motifs present in the cytoplasmic tail. 202
A Vector Design that Allows Fast and Convenient Production of Differently Tagged Proteins. 200
Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic 191
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt 188
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation 186
Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome. 186
BH3-only proteins: the death-puppeteer's wires 185
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) 182
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variability. 182
PML gene is not involved in the regulation of MHC class I expression in human cell lines. 181
Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients 177
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 177
Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic 175
Cellular mechanisms of artificial peptides binding to HLA. 174
CD1d expression and function in B-cell lymphoproliferative disorders 174
High frequency of development of B cell lymphoproliferation and diffuse large B cell lymphoma in Dbl knock-in mice. 173
CX3CR1 is expressed by human B lymphocytes and mediates CX3CL1 driven chemotaxis of tonsil centrocytes. 170
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements 167
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: A Possible Role for RANK/RANKL Pathway 164
Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds 163
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. 162
The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model 162
Analysis of the stepwise genetic changes that occurred in an AIDS-related Burkitt\'s lymphoma. 160
Expression of Ig receptors with distinctive features indicating antigen selection by marginal zone B cells from human spleen. 159
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 159
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma. 155
A soluble form of CTLA-4 is present in serum of paediatric patients with acute lymphoblastic leukaemia. 153
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy 153
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines 153
SH3BGRL3 binds to myosin 1c in a calcium dependent manner and modulates migration in the MDA-MB-231 cell line 153
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia 149
Apoptosis of Burkitt\'s lymphoma cells induced by specific interaction of surface IgM with a self-antigen. Implications for lymphomagenesis in AIDS. 147
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach 147
Adoptive immunotherapy mediated by ex vivo expanded NKT cells against CD1D-expressing lymphoid neoplasms. 146
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. 144
Inhibitory receptors CD85j, LAIR-1 and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes 144
Establishment and characterization of a novel fibroblastic cell line (Sci13d) derived from the broncho-alveolar lavage of a patient with fibrotic hypersensitivity pneumonitis 144
Effects of fatty acid oxidation inhibitors on in vitro stimulated Chronic Lymphocytic Leukemia cells 143
CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates α-galactosylceramide presentation to natural killer T lymphocytes 140
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukaemia. 139
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas 139
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 137
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B-cells 136
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia 136
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia 135
Trends in Stem Cell Proliferation and Cancer Research: BH3-only proteins in cancer and apoptosis 135
Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates 133
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients 131
Identification of three subgroups of B-CELL chronic lymphocytic leukemia based upon mutations of BCL-6 and Ig V genes 130
Hepatocyte growth factor: A microenvironmental resource for leukemic cell growth 130
Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. 129
IMMUNOGLOBULIN V GENE MUTAITON STATUS AND CD38 EXPRESSION AS NOVEL PROGNOSTIC INDICATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA 127
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma. 127
Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes 127
Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. 126
CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis 126
Role of the B-cell receptor in chronic lymphocytic leukemia: where do we stand? 119
Immunoglobulin V genes and CD38 expression analysis in B cell chronic lymphocytic leukemia. Blood. Letter 118
Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. 118
IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukaemia 117
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 117
Assessment of RT-PCR detection of human mammaglobin for the disgnosis of breast cancer derived pleural effusion. 116
Effect of blocking or cross-linking of inhibitory receptors on T cell proliferation and cytokine production. 114
TRANSFECTION OF THE C-MYC ONCOGENE INTO NORMAL EBV-HARBORING B CELLS RESULTS IN NEW PHENOTYPIC AND FUNCTIONAL FEATURES RESEMBLING THOSE OF BURKITT LYMPHOMA CELLS AND NORMAL CENTROBLASTS 113
Abstract IgH and L chain variable region gene sequence analyses of twelve synovial tissue-derived B cell lines producing IgA, IgG, and IgM rheumatoid factors structure/function comparisons of antigenic specificity, V gene sequence, and Ig isotype. 112
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases 112
A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation 110
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights 106
Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia 106
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 104
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? 104
Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors. 103
Targeting the Bcl-2 family in B-cell chronic lymphocytic leukemia 99
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells 99
A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d+ Expression 96
Examples of in vivo isotype switching in IgM+ chronic lymphocytic leukemia B cells 96
Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. 96
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors 93
BH3-only proteins in cancer and apoptosis 90
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study 83
A pilot study on school of medicine students’ perception of ethical issues related to human specimens in anatomical museums 82
La forma solubile di CTLA-4 è espressa nel siero di pazienti pediatrici affetti da leucemia linfoblastica acuta. 82
Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia 79
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells 78
null 78
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course 78
Computational-based PET/CT evaluation can detect and stage the metabolic changes linked to the RANK/RANKL loop, in chronic lymphocytic leukemia 76
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol 57
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study 56
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells 55
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. 55
Unraveling the bone-tissue microenvironment in Chronic Lymphocytic Leukemia 54
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia 53
Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and lgV genes 51
Ig h and l chain variable region gene sequence analyses of twelve synovial tissue-derived b cell lines producing iga, igg, and igm rheumatoid factors structure/function comparisons of antigenic specificity, v gene sequence, and IG isotype 50
Chronic lymphocytic leukemia often arises by a multiclonal selection process 47
Totale 13.179
Categoria #
all - tutte 45.269
article - articoli 42.364
book - libri 0
conference - conferenze 2.500
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 405
Totale 90.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.011 52 70 74 100 39 66 64 232 33 92 53 136
2022/20231.102 113 102 11 142 153 176 4 114 157 7 102 21
2023/2024802 30 85 22 80 79 169 67 53 41 19 56 101
2024/20251.996 73 139 61 145 214 210 207 326 70 85 228 238
2025/20263.741 465 103 212 307 481 284 564 207 222 406 254 236
2026/2027340 340 0 0 0 0 0 0 0 0 0 0 0
Totale 13.356